PL2793862T3 - Sposób współprzetwarzania i preparat związku będącego prolekiem inhibitora przyłączania HIV i zaróbek - Google Patents

Sposób współprzetwarzania i preparat związku będącego prolekiem inhibitora przyłączania HIV i zaróbek

Info

Publication number
PL2793862T3
PL2793862T3 PL12809969T PL12809969T PL2793862T3 PL 2793862 T3 PL2793862 T3 PL 2793862T3 PL 12809969 T PL12809969 T PL 12809969T PL 12809969 T PL12809969 T PL 12809969T PL 2793862 T3 PL2793862 T3 PL 2793862T3
Authority
PL
Poland
Prior art keywords
excipients
preparation
processing method
prodrug compound
hiv attachment
Prior art date
Application number
PL12809969T
Other languages
English (en)
Inventor
Shih-Ying Chang
Donald C. Kientzler
Deniz Erdemir
San Kiang
Tamar Rosenbaum
Original Assignee
VIIV Healthcare UK(No.4) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIIV Healthcare UK(No.4) Limited filed Critical VIIV Healthcare UK(No.4) Limited
Publication of PL2793862T3 publication Critical patent/PL2793862T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL12809969T 2011-12-21 2012-12-18 Sposób współprzetwarzania i preparat związku będącego prolekiem inhibitora przyłączania HIV i zaróbek PL2793862T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161578689P 2011-12-21 2011-12-21
US13/716,306 US9248139B2 (en) 2011-12-21 2012-12-17 Co-processing method and formulations for HIV attachment inhibitor prodrug compound and excipients
EP12809969.4A EP2793862B1 (en) 2011-12-21 2012-12-18 Co-processing method and formulation for hiv attachment inhibitor prodrug compound and excipients

Publications (1)

Publication Number Publication Date
PL2793862T3 true PL2793862T3 (pl) 2017-06-30

Family

ID=48654800

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12809969T PL2793862T3 (pl) 2011-12-21 2012-12-18 Sposób współprzetwarzania i preparat związku będącego prolekiem inhibitora przyłączania HIV i zaróbek

Country Status (16)

Country Link
US (2) US9248139B2 (pl)
EP (1) EP2793862B1 (pl)
JP (1) JP6120876B2 (pl)
CN (1) CN104023709B (pl)
CY (1) CY1118507T1 (pl)
DK (1) DK2793862T3 (pl)
ES (1) ES2617512T3 (pl)
HR (1) HRP20170164T1 (pl)
HU (1) HUE031758T2 (pl)
LT (1) LT2793862T (pl)
PL (1) PL2793862T3 (pl)
PT (1) PT2793862T (pl)
RS (1) RS55685B1 (pl)
SI (1) SI2793862T1 (pl)
SM (2) SMT201700126T1 (pl)
WO (1) WO2013096239A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013130785A2 (en) * 2012-03-01 2013-09-06 Bristol-Myers Squibb Company Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ526608A (en) * 2000-12-22 2006-06-30 Baxter Int Method for preparing submicron particle suspensions
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
CA2531766C (en) 2003-09-11 2012-11-27 Tibotec Pharmaceuticals Ltd. Entry inhibitors of the hiv virus
JP2007516259A (ja) * 2003-12-09 2007-06-21 メッドクリスタルフォームズ、エルエルシー 活性剤との混合相共結晶の調製方法
US7745625B2 (en) * 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
CN102143739B (zh) 2008-09-04 2014-12-17 百时美施贵宝公司 用于最优化传递hiv附着抑制剂的稳定的药用组合物

Also Published As

Publication number Publication date
LT2793862T (lt) 2017-03-27
US20160102093A1 (en) 2016-04-14
HRP20170164T1 (hr) 2017-04-07
DK2793862T3 (en) 2017-01-16
ES2617512T3 (es) 2017-06-19
HUE031758T2 (en) 2017-07-28
SI2793862T1 (sl) 2017-03-31
PT2793862T (pt) 2017-02-20
CY1118507T1 (el) 2017-07-12
CN104023709B (zh) 2016-06-29
US9248139B2 (en) 2016-02-02
US20130164345A1 (en) 2013-06-27
CN104023709A (zh) 2014-09-03
SMT201700126B (it) 2017-03-08
RS55685B1 (sr) 2017-07-31
EP2793862B1 (en) 2016-12-07
WO2013096239A1 (en) 2013-06-27
SMT201700126T1 (it) 2017-03-08
EP2793862A1 (en) 2014-10-29
JP6120876B2 (ja) 2017-04-26
JP2015503522A (ja) 2015-02-02

Similar Documents

Publication Publication Date Title
NO2025034I1 (no) Remdesivir or a pharmaceutically acceptable salt or ester thereof - forlengelse
NO2021040I1 (no) glecaprevir or a pharmaceutically acceptable salt or ester thereof- forlenget SPC
NO2021033I1 (no) Selineksor eller et farmasøytisk akseptabelt salt derav
NO2023040I1 (no) Atogepant or a pharmaceutically acceptable salt thereof
NO2021039I1 (no) pibrentasvir or a pharmaceutically acceptable salt thereof - forlenget SPC
NL301191I2 (nl) voxelotor of een tautomeer of farmaceutisch aanvaardbaar zout daarvan
NO2019019I1 (no) Doravirin eller et farmasøytisk akseptabelt salt derav
IL231650A0 (en) Pyrazoloquinoline derivative
SI2760831T1 (sl) Inhibitorji replikacije virusov
DK3011936T3 (da) Vævsmanipulerede konstrukter
BR112014014232A2 (pt) composto e método para a preparação de um composto
BR112013018875A2 (pt) métodos e composições para a preparação de noribogaína a partir de voacangina
IL229270A0 (en) Hepatitis c virus inhibitors
BR112014011685A2 (pt) composto, utilização de um composto e método
IL227302A0 (en) Methods for preparing a pro-drug compound that inhibits HIV conjugation and intermediates
DE112012002395A5 (de) Lagerung einer Nockenwelle
PT2714910T (pt) Composição imunogénica
BR112013024413A2 (pt) compostos e métodos para a preparação de diarilpropanos
EP2785370A4 (en) VACCINE AGAINST FALCIPARUM MALARIA
FR2978048B1 (fr) Composition vaccinale contre le paludisme
HRP20180587T1 (hr) Pripravak krutog surfaktanta
BR112013023038A2 (pt) composto e uso de um composto
EP2753771A4 (en) TEMPORARY PROTECTION
LT2793862T (lt) Živ prisitvirtinimo inhibitoriaus provaisto junginio bei užpildų kompozicija ir bendro apdorojimo būdas
ITMI20131683A1 (it) Componente strutturale microelettromeccanico e procedimento per la produzione di un componente strutturale microelettromeccanico